is semaglutide hard on the kidneys How GLP-1s impact heart and of veterans with type 2 diabetes Semaglutide: A New Era in
Description
More approvals could push prices to Tier 3 Health Canada is currently reviewing seven other submissions for generic semaglutide by different companies and expects to make regulatory decisions on more of these submissions in the coming weeks and months [Source: canada.ca/en/health-canada/news/2026/05/canada-approves-second-generic-semaglutide-the-first-g7-country-to-do-so.html]
GLP-1s are not going anywhere pharma manufacturers continue to evolve their GLP-1/GIP product offerings (e.g., Eli Lillys Zepbound is the newest on the market), and the number of addressable indications is increasing (e.g., recent clinical evidence that may merit further FDA approval of GLP-1s for cardio-metabolic, nephrological and neurological indications)
World J Diabetes 2018;9:4052
Because retatrutide is investigational, rare or long-term adverse effects may become clearer only after larger studies and longer follow-up
